Stantec (STN) Financials

$103.79 +1.96 (+1.93%)

As of 02:17 PM Eastern

Annual Income Statements for Stantec

This table shows Stantec's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Net Income / (Loss) Attributable to Common Shareholders	251	240	183	157	134	150	35	-2,971	60
Consolidated Net Income / (Loss)	251	240	183	157	134	150	35	77	97
Net Income / (Loss) Continuing Operations	251	240	183	157	125	150	126	-2,971	60
Total Pre-Tax Income	323	309	183	206	125	150	126	-2,971	135
Total Operating Income	294	272	237	243	168	221	152	-2,991	122
Total Gross Profit	3,972	3,730	1,786	1,537	1,513	1,548	1,330	-1,780	1,247
Total Revenue	5,107	4,801	4,227	3,586	3,725	3,677	3,139	21	3,191
Operating Revenue	5,107	4,801	4,227	3,586	3,725	3,677	3,139	21	3,191
Total Cost of Revenue	1,134	1,071	2,499	2,045	2,257	2,172	1,849	1,801	1,981
Operating Cost of Revenue	1,134	1,071	2,499	2,045	2,257	2,172	1,849	1,801	1,981
Total Operating Expenses	3,678	3,458	1,492	1,294	1,300	1,284	1,138	1,210	1,088
Selling, General & Admin Expense	1,588	1,489	1,288	1,114	1,061	1,105	1,054	1,119	994
Depreciation Expense	135	138	132	127	138	134	37	41	38
Amortization Expense	86	77	77	47	42	52	48	58	56
Other Operating Expenses / (Income)	1,845	1,755	-5.17	-13	-1.65	-8.48	0.07	-7.95	0.15
Impairment Charge	24	0.23	-	19	62	1.54	-	-	-
Total Other Income / (Expense), net	-43	-32	-54	-37	-44	-71	-26	19	-25
Interest Expense	73	70	54	30	39	54	21	21	21
Other Income / (Expense), net	29	38	-	-7.36	-5.02	-18	-4.98	-3.34	-3.50
Weighted Average Basic Shares Outstanding	114.07M	111.23M	110.81M	111.33M	111.01M	111.21M	111.86M	0.00	1.22
Weighted Average Diluted Shares Outstanding	114.07M	111.23M	110.81M	111.33M	111.01M	111.21M	111.86M	0.00	-
Weighted Average Basic & Diluted Shares Outstanding	228.13M	222.46M	110.81M	111.33M	111.01M	111.21M	111.86M	0.00	-

No quarterly income statements for Stantec are available.

This table details how cash moves in and out of Stantec's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Net Change in Cash & Equivalents	-86	155	18	-29	261	3,773	3,172	23	3,226
Net Cash From Operating Activities	419	394	62	16	63	2.23	2.71	3,366	0.00
Net Cash From Continuing Operating Activities	323	323	62	16	63	2.23	2.71	3,366	0.00
Net Income / (Loss) Continuing Operations	251	240	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Consolidated Net Income / (Loss)	251	240	-	-	-	-	-	-	-
Depreciation Expense	135	138	42	42	45	-	-	-	-
Non-Cash Adjustments To Reconcile Net Income	74	62	-90	-46	28	2.23	2.71	3,589	-
Changes in Operating Assets and Liabilities, net	-138	-117	33	-28	-51	-	-	15	-
Net Cash From Investing Activities	-420	-153	0.00	0.00	0.00	3,803	3,200	-47	3,318
Net Cash From Continuing Investing Activities	-420	-153	0.00	0.00	0.00	3,803	3,200	-47	3,318
Acquisitions	-385	-57	-	-	-	-	-	-	-
Purchase of Investments	-97	-160	-	-	-	-	-	-	-
Sale and/or Maturity of Investments	51	55	-	-	-	-	-	-	-
Other Investing Activities, net	11	9.17	-	-	-	3,803	3,200	-	3,318
Net Cash From Financing Activities	-106	-83	-45	-45	197	-31	-31	-219	-92
Net Cash From Continuing Financing Activities	-30	-30	-45	-45	197	-31	-31	-219	-92
Repayment of Debt	35	-439	-45	-45	-36	-31	-31	0.00	-93
Payment of Dividends	-65	-64	-	-	-	-	-	44	0.60
Issuance of Debt	0.00	264	0.00	-	234	0.00	-	163	-
Issuance of Common Equity	0.00	210	-	-	-	-	-	11	-
Other Financing Activities, net	0.00	-0.53	-	-	-	-	-	-	-

No quarterly cash flow statements for Stantec are available.

This table presents Stantec's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	1/1/2023	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Total Assets	4,831	4,368	3,946	4,090	3,440	3,515	2,938	3,086	3,189
Total Current Assets	1,770	1,721	1,432	1,303	1,227	1,218	1,198	1,278	1,178
Cash & Equivalents	159	267	110	152	227	172	136	197	157
Accounts Receivable	1,422	1,278	1,169	645	579	630	643	978	600
Prepaid Expenses	45	41	36	36	31	33	42	43	46
Current Deferred & Refundable Income Taxes	45	55	48	67	37	28	35	49	35
Plant, Property, & Equipment, net	-46	-39	-36	183	188	221	212	-17	159
Plant, Property & Equipment, gross	-46	-39	-36	183	188	221	212	-17	159
Total Noncurrent Assets	3,160	2,727	2,583	2,605	2,025	2,077	1,528	1,819	1,852
Goodwill	1,884	1,571	1,502	1,710	1,312	1,273	1,188	1,237	1,360
Intangible Assets	297	201	237	292	143	169	182	209	335
Noncurrent Deferred & Refundable Income Taxes	83	70	33	38	33	25	16	18	19
Other Noncurrent Operating Assets	897	885	811	565	537	610	136	346	130
Total Liabilities & Shareholders' Equity	4,831	4,368	3,946	4,090	3,440	3,515	2,938	3,086	3,189
Total Liabilities	2,785	2,511	2,474	2,523	1,928	2,069	1,540	1,576	1,718
Total Current Liabilities	1,079	955	841	923	774	776	655	718	798
Accounts Payable	707	638	580	497	452	444	416	560	534
Current Deferred Revenue	349	301	242	-	-	-	-	149	150
Current Deferred & Payable Income Tax Liabilities	22	16	19	21	19	22	28	8.74	1.34
Total Noncurrent Liabilities	1,661	1,517	1,597	1,600	1,154	1,293	885	837	919
Long-Term Debt	973	850	921	935	497	627	649	588	691
Capital Lease Obligations	79	77	73	427	412	454	0.00	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	44	20	26	68	58	65	51	43	59
Noncurrent Employee Benefit Liabilities	16	22	24	46	71	66	50	36	38
Other Noncurrent Operating Liabilities	549	548	553	126	115	81	135	170	131
Total Equity & Noncontrolling Interests	2,045	1,857	1,472	1,567	1,512	1,447	1,399	2,999	1,471
Total Preferred & Common Equity	0.00	0.00	0.00	1,567	1,512	1,445	1,397	2,997	1,470
Total Common Equity	0.00	0.00	0.00	1,567	1,512	1,445	1,397	2,997	1,470
Noncontrolling Interest	2,045	1,857	1,472	0.39	0.63	1.23	1.32	2.38	0.60

No quarterly balance sheets for Stantec are available.

This table displays calculated financial ratios and metrics derived from Stantec's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	6.37%	13.57%	17.90%	-3.75%	1.31%	17.15%	14,860.76%	-99.34%	0.00%
EBITDA Growth	2.48%	25.80%	9.63%	29.66%	-35.65%	68.52%	107.98%	-1,459.99%	0.00%
EBIT Growth	4.31%	31.09%	0.48%	44.22%	-19.74%	38.83%	104.90%	-2,628.76%	0.00%
NOPAT Growth	8.12%	14.95%	27.68%	10.12%	-23.88%	45.91%	107.24%	-2,479.39%	0.00%
Net Income Growth	4.72%	31.34%	16.20%	17.11%	-10.47%	331.34%	-54.94%	-20.62%	0.00%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	6.33%	531.51%	290.64%	-74.79%	2,734.05%	-17.57%	-99.92%	0.00%	0.00%
Free Cash Flow Firm Growth	-134.58%	241.93%	132.12%	-209.48%	237.73%	-157.49%	117.24%	0.00%	0.00%
Invested Capital Growth	16.79%	-3.78%	5.16%	26.63%	-6.66%	26.83%	-12.54%	9.58%	0.00%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	77.79%	77.70%	42.26%	42.86%	40.63%	42.09%	42.38%	-8,486.36%	39.10%
EBITDA Margin	8.98%	9.33%	8.42%	9.05%	6.72%	10.58%	7.36%	-13,796.59%	6.67%
Operating Margin	5.76%	5.67%	5.60%	6.77%	4.52%	6.01%	4.83%	-14,254.92%	3.82%
EBIT Margin	6.34%	6.46%	5.60%	6.57%	4.38%	5.53%	4.67%	-14,270.83%	3.71%
Profit (Net Income) Margin	4.92%	4.99%	4.32%	4.38%	3.60%	4.07%	1.11%	367.42%	3.04%
Tax Burden Percent	77.69%	77.63%	100.00%	76.31%	107.54%	100.00%	27.67%	-2.59%	72.18%
Interest Burden Percent	99.87%	99.56%	77.14%	87.40%	76.38%	73.64%	85.65%	99.24%	113.64%
Effective Tax Rate	0.00%	0.00%	0.00%	23.69%	0.00%	0.00%	0.00%	0.00%	27.82%
Return on Invested Capital (ROIC)	10.79%	10.60%	9.28%	8.33%	8.28%	11.76%	8.53%	-115.44%	5.08%
ROIC Less NNEP Spread (ROIC-NNEP)	5.24%	6.53%	3.41%	4.21%	2.11%	-3.80%	36.23%	-630.21%	8.60%
Return on Net Nonoperating Assets (RNNOA)	2.08%	3.11%	1.93%	1.87%	0.79%	-1.22%	-6.95%	118.89%	1.52%
Return on Equity (ROE)	12.87%	13.71%	11.21%	10.20%	9.07%	10.53%	1.58%	3.45%	6.60%
Cash Return on Invested Capital (CROIC)	-4.70%	14.45%	4.25%	-15.17%	15.16%	-11.90%	21.91%	-124.59%	0.00%
Operating Return on Assets (OROA)	7.03%	7.46%	5.72%	6.25%	4.69%	6.31%	4.87%	-95.44%	3.71%
Return on Assets (ROA)	5.46%	5.77%	4.42%	4.17%	3.86%	4.64%	1.15%	2.46%	3.05%
Return on Common Equity (ROCE)	0.00%	0.00%	5.39%	10.20%	9.06%	10.52%	1.58%	3.45%	6.60%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	10.03%	8.87%	10.37%	2.49%	2.57%	6.61%
Net Operating Profit after Tax (NOPAT)	294	272	237	185	168	221	152	-2,093	88
NOPAT Margin	5.76%	5.67%	5.60%	5.17%	4.52%	6.01%	4.83%	-9,978.45%	2.76%
Net Nonoperating Expense Percent (NNEP)	5.55%	4.07%	5.87%	4.12%	6.17%	15.56%	-27.71%	514.77%	-3.52%
Return On Investment Capital (ROIC_SIMPLE)	9.50%	9.77%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	22.21%	22.30%	59.11%	57.05%	60.59%	59.08%	58.91%	8,586.36%	62.08%
SG&A Expenses to Revenue	31.09%	31.01%	30.46%	31.07%	28.47%	30.05%	33.58%	5,332.20%	31.14%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	72.03%	72.03%	35.29%	36.08%	34.89%	34.91%	36.27%	5,768.56%	34.10%
Earnings before Interest and Taxes (EBIT)	324	310	237	236	163	203	147	-2,994	118
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	459	448	356	325	250	389	231	-2,894	213
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	3.90	2.31	2.08	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	61.26	953.37	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.75	1.84	1.25	1.70	0.94	0.82	0.00	0.00	0.00
Price to Earnings (P/E)	35.65	36.79	28.93	38.86	26.03	20.11	0.00	0.00	0.00
Dividend Yield	0.85%	0.98%	1.52%	1.20%	1.98%	2.15%	2.69%	1.95%	1.97%
Earnings Yield	2.81%	2.72%	3.46%	2.57%	3.84%	4.97%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.05	4.51	3.02	2.96	2.14	1.88	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.33	2.36	1.87	2.05	1.13	1.08	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	25.91	25.32	22.18	22.65	16.82	10.17	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	36.74	36.55	33.36	31.23	25.79	19.46	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	40.42	41.67	33.36	39.68	25.02	17.90	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	28.38	28.78	126.58	460.59	66.48	1,771.32	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	30.58	72.82	0.00	13.66	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.51	0.50	0.61	0.89	0.63	0.77	0.49	0.20	0.52
Long-Term Debt to Equity	0.51	0.50	0.61	0.87	0.60	0.75	0.46	0.20	0.47
Financial Leverage	0.40	0.48	0.57	0.45	0.37	0.32	-0.19	-0.19	0.18
Leverage Ratio	2.36	2.50	2.54	2.45	2.35	2.27	1.37	1.40	2.17
Compound Leverage Factor	2.35	2.49	1.96	2.14	1.80	1.67	1.17	1.39	2.46
Debt to Total Capital	33.96%	33.29%	37.98%	47.20%	38.48%	43.58%	32.85%	16.39%	34.05%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	1.34%	1.49%	1.41%	1.71%	0.00%	3.07%
Long-Term Debt to Total Capital	33.96%	33.29%	37.98%	45.86%	37.00%	42.17%	31.14%	16.39%	30.98%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	66.04%	66.71%	62.02%	0.01%	0.03%	0.05%	0.06%	0.07%	0.03%
Common Equity to Total Capital	0.00%	0.00%	0.00%	52.78%	61.49%	56.37%	67.09%	83.55%	65.92%
Debt to EBITDA	2.29	2.07	2.91	4.32	3.78	2.87	2.96	-0.20	3.57
Net Debt to EBITDA	1.95	1.47	2.60	3.85	2.87	2.43	2.35	-0.13	2.77
Long-Term Debt to EBITDA	2.29	2.07	2.91	4.19	3.63	2.78	2.81	-0.20	3.25
Debt to NOPAT	3.58	3.41	4.37	7.56	5.62	5.05	4.52	-0.28	8.63
Net Debt to NOPAT	3.04	2.42	3.91	6.74	4.27	4.27	3.57	-0.18	6.70
Long-Term Debt to NOPAT	3.58	3.41	4.37	7.34	5.40	4.89	4.28	-0.28	7.85
Altman Z-Score	3.38	3.65	2.65	2.91	2.79	2.54	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	100.00%	100.00%	51.89%	0.03%	0.06%	0.09%	0.08%	0.07%	0.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	1.64	1.80	1.75	1.41	1.59	1.57	1.83	1.78	1.48
Quick Ratio	1.47	1.62	1.56	0.92	1.11	1.10	1.26	1.64	0.95
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-128	371	108	-338	308	-224	389	-2,259	0.00
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-1.77	5.26	2.00	-11.38	7.99	-4.17	18.52	-109.77	0.00
Operating Cash Flow to Interest Expense	5.78	5.59	1.15	0.54	1.64	0.04	0.13	163.53	0.00
Operating Cash Flow Less CapEx to Interest Expense	5.78	5.59	1.15	0.54	1.64	0.04	0.13	165.81	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	1.11	1.16	1.02	0.95	1.07	1.14	1.04	0.01	1.00
Accounts Receivable Turnover	3.78	3.92	4.66	5.86	6.16	5.77	3.87	0.03	5.32
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	19.32	18.22	16.99	0.00	0.00	20.04
Accounts Payable Turnover	1.69	1.76	4.74	4.31	5.04	5.05	3.79	3.29	3.71
Days Sales Outstanding (DSO)	96.51	93.01	78.28	62.26	59.22	63.21	94.29	13,729.23	68.65
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	216.48	207.63	77.07	84.61	72.43	72.23	96.30	110.87	98.48
Cash Conversion Cycle (CCC)	-119.98	-114.62	1.21	-22.35	-13.22	-9.02	-2.01	13,618.37	-29.83
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	2,938	2,516	2,614	2,486	1,963	2,103	1,658	1,896	1,730
Invested Capital Turnover	1.87	1.87	1.66	1.61	1.83	1.96	1.77	0.01	1.84
Increase / (Decrease) in Invested Capital	422	-99	128	523	-140	445	-238	166	0.00
Enterprise Value (EV)	11,887	11,336	7,895	7,354	4,211	3,959	0.00	0.00	0.00
Market Capitalization	8,949	8,820	5,280	6,104	3,491	3,012	0.00	0.00	0.00
Book Value per Share	$0.00	$0.00	$0.00	$14.11	$13.59	$12.92	$12.49	$3,525,676,758.82	$1,205,118,530.33
Tangible Book Value per Share	($19.11)	($15.99)	($17.70)	($3.92)	$0.51	$0.03	$0.25	$1,825,057,303.53	($184,150,065.57)
Total Capital	3,097	2,783	2,724	2,968	2,459	2,564	2,083	3,587	2,230
Total Debt	1,052	926	1,035	1,401	946	1,117	684	588	759
Total Long-Term Debt	1,052	926	1,035	1,361	910	1,081	649	588	691
Net Debt	893	659	925	1,249	719	945	542	382	589
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-47	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	533	499	503	268	263	306	443	364	284
Debt-free Net Working Capital (DFNWC)	691	766	612	420	490	478	579	560	448
Net Working Capital (NWC)	691	766	612	380	453	442	544	560	379
Net Nonoperating Expense (NNE)	43	32	54	28	34	71	117	-2,171	-9.13
Net Nonoperating Obligations (NNO)	893	659	925	919	451	657	260	-1,103	260
Total Depreciation and Amortization (D&A)	135	138	119	89	87	186	84	99	94
Debt-free, Cash-free Net Working Capital to Revenue	10.43%	10.39%	11.89%	7.47%	7.05%	8.32%	14.13%	1,734.09%	8.91%
Debt-free Net Working Capital to Revenue	13.54%	15.95%	14.48%	11.70%	13.14%	13.01%	18.45%	2,671.21%	14.03%
Net Working Capital to Revenue	13.54%	15.95%	14.48%	10.59%	12.16%	12.03%	17.32%	2,671.21%	11.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$1.80	$0.00	$1.74	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	114.07M	114.07M	110.81M	111.33M	111.01M	111.21M	0.00	1.00	0.00
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$1.80	$0.00	$1.74	$0.00	$0.85	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	114.07M	114.07M	110.81M	111.33M	111.01M	111.21M	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$1.74	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	228.13M	114.07M	110.81M	111.33M	111.01M	111.21M	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	223	191	166	200	161	156	106	-2,093	88
Normalized NOPAT Margin	4.36%	3.97%	3.92%	5.58%	4.32%	4.24%	3.38%	-9,978.45%	2.76%
Pre Tax Income Margin	6.33%	6.43%	4.32%	5.74%	3.35%	4.07%	4.00%	-14,162.12%	4.22%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.46	4.40	4.37	7.94	4.23	3.79	6.97	-145.46	5.56
NOPAT to Interest Expense	4.06	3.86	4.37	6.25	4.36	4.12	7.21	-101.71	4.13
EBIT Less CapEx to Interest Expense	4.46	4.40	4.37	7.94	4.23	3.79	6.97	-143.19	5.56
NOPAT Less CapEx to Interest Expense	4.06	3.86	4.37	6.25	4.36	4.12	7.21	-99.44	4.13
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	26.00%	26.82%	0.00%	0.00%	0.00%	0.00%	0.00%	-57.22%	-0.61%
Augmented Payout Ratio	26.00%	26.82%	0.00%	0.00%	0.00%	0.00%	0.00%	-57.22%	-0.61%

No quarterly metrics and ratios for Stantec are available.

Frequently Asked Questions About Stantec's Financials

When does Stantec's fiscal year end?

According to the most recent income statement we have on file, Stantec's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Stantec's net income changed over the last 8 years?

Stantec's net income appears to be on an upward trend, with a most recent value of $251.04 million in 2024, rising from $97.11 million in 2016. The previous period was $239.74 million in 2023. See Stantec's forecast for analyst expectations on what’s next for the company.

What is Stantec's operating income?

Stantec's total operating income in 2024 was $294.10 million, based on the following breakdown:

Total Gross Profit: $3.97 billion
Total Operating Expenses: $3.68 billion

How has Stantec revenue changed over the last 8 years?

Over the last 8 years, Stantec's total revenue changed from $3.19 billion in 2016 to $5.11 billion in 2024, a change of 60.1%.

How much debt does Stantec have?

Stantec's total liabilities were at $2.79 billion at the end of 2024, a 10.9% increase from 2023, and a 62.2% increase since 2016.

How much cash does Stantec have?

In the past 8 years, Stantec's cash and equivalents has ranged from $109.59 million in 2022 to $267.31 million in 2023, and is currently $158.68 million as of their latest financial filing in 2024.

How has Stantec's book value per share changed over the last 8 years?

Over the last 8 years, Stantec's book value per share changed from 1,205,118,530.33 in 2016 to 0.00 in 2024, a change of -100.0%.

Related Companies

This page (NYSE:STN) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stantec (STN) Financials

Frequently Asked Questions About Stantec's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stantec (STN) Financials

Annual Income Statements for Stantec

Quarterly Income Statements for Stantec

Annual Cash Flow Statements for Stantec

Quarterly Cash Flow Statements for Stantec

Annual Balance Sheets for Stantec

Quarterly Balance Sheets for Stantec

Annual Metrics And Ratios for Stantec

Quarterly Metrics And Ratios for Stantec

Frequently Asked Questions About Stantec's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools